Q32 Bio Inc. Increase (Decrease) in Notes Payable, Current
Q32 Bio Inc. (QTTB) reported Increase (Decrease) in Notes Payable, Current of $15.90 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInNotesPayableCurrent · last filed 2026-03-10
- Q32 Bio Inc. increase (decrease) in notes payable, current for the quarter ending 2025-12-31 was $0.00.
- Q32 Bio Inc. increase (decrease) in notes payable, current for the quarter ending 2025-09-30 was $0.00.
- Q32 Bio Inc. increase (decrease) in notes payable, current for the quarter ending 2024-12-31 was $0.00.
- Q32 Bio Inc. increase (decrease) in notes payable, current for the quarter ending 2024-09-30 was $0.00.
- Q32 Bio Inc. increase (decrease) in notes payable, current for fiscal 2025 was $15.90M, a 0.00% change from fiscal 2024.
- Q32 Bio Inc. increase (decrease) in notes payable, current for fiscal 2024 was $15.90M.
| Period end | Increase (Decrease) in Notes Payable, Current 3 month | Increase (Decrease) in Notes Payable, Current 6 month | Increase (Decrease) in Notes Payable, Current 9 month | Increase (Decrease) in Notes Payable, Current 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $0.00 derived: sum of 2 quarters · filed 2026-03-10 | $15.90M 10-K · filed 2026-03-10 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $15.90M 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $15.90M 10-Q · filed 2025-08-06 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $0.00 derived: sum of 2 quarters · filed 2025-03-11 | $0.00 derived: sum of 3 quarters · filed 2025-03-11 | $15.90M 10-K · filed 2025-03-11 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $15.90M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $15.90M 10-Q · filed 2024-08-08 | ||
| 2024-03-31 | $15.90M 10-Q · filed 2025-05-08 |